DASEA's 3D-Bioengineered Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Successfully Obtain Dual CBER & CDER Filings from US FDA

作者:REGEN-αGEEK

浏览量:1751

2025-01-09

分享

On January 7, 2025, REGEN-αGEEK kicked off the new year with major news: its human umbilical cord mesenchymal stem cell-derived exosomes, prepared using the self-developed DASEA Bio-manufacturing Platform with 3D cultivation, have successfully obtained dual Drug Master File (DMF) filings with both the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER) under the US Food and Drug Administration (FDA).


We cordially invites you to
explore the infinite potential of
stem cells and exosomes

Scan the QR Code to learn more about us
x-index2.png

电话icon(1).svg 0755 2641 2015

email.svg Enquiry@regengeek.com

dz.svg Headquarters: No. 301, Building 6, Juanhu Science and Innovation Park, No. 500, Shuiyue Pavilion East Road, Xiashi Street, Haining City, Jiaxing City, Zhejiang Province, China.

dz.svg Business center: RM. 503, Wanwei Building, No.5 5th Gongye Road, Nanshan District, Shenzhen City, Guangdong Province, China.

© 2024 REGEN-αGEEK (Haining) Biotechnology Co., Ltd.

友情链接

x-slide1.png
x-slide2.svg Click here for the latest cell industry preparation solutions